Role of TTV During First-line Immunotherapy Treatment in Patients With Renal Cell Carcinoma

NCT07018037 · clinicaltrials.gov ↗
RECRUITING
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Regina Elena Cancer Institute